Acknowledgement at the health event highlighted Mika’s ability to translate market insights into growth strategies through cross-functional alignment.
— Mastering life sciences growth through seamless team alignment, Mika Yamakawa, Director of Business Strategy & Operations at Gilead Sciences, Inc., earned the “Excellence in Healthcare Award” at Health 2.0 Conference’s Dubai Edition. The prestigious event took place from December 8–10, 2025, at the InterContinental DFC, Dubai, UAE. The global platform highlighted her ability to translate market insights into sustained organizational momentum.
Mika Yamakawa is a strategic operations leader with a robust background in business planning and execution within the life sciences industry. She holds a graduate degree from McGill University’s Desautels Faculty of Management and has held roles where she drove alignment between commercial, medical, and operational teams to deliver on growth plans.
At Gilead Sciences, she is known for her ability to transform insights into actionable strategies, build strong cross-functional partnerships, and lead initiatives that enhance organizational performance. Mika brings a polished analytical mindset along with a collaborative leadership style, committed to advancing excellence and long-term value creation.
After receiving the honor at the event, Mika expressed, “I’m truly honored to receive this ‘Excellence in Healthcare Award’. I feel very fortunate to work in a supportive environment with exceptional colleagues. This recognition is especially meaningful because it affirms that what we did/are doing is contributing to patients and to society. I’ll continue to strive to deliver value for all stakeholders, especially patients and physicians.”
This accolade affirms Yamakawa’s pivotal role in bridging strategy with execution, empowering Gilead Sciences Inc. to accelerate breakthroughs in patient care through disciplined alignment and visionary operations.
Health 2.0 Conference
Health 2.0 Conference gathers innovators across healthcare, pharmaceuticals, biotechnology, medical technology, and wellness to accelerate revolutionary insights and ignite forward-thinking exchanges. Across three intensive days, policymakers, scientists, investors, and practitioners explore transformative topics including AI diagnostics, patient safety measures, hospital efficiency, precision medicine, advanced pharmaceuticals, digital health solutions, and more. Through compelling keynotes, expert roundtables, and strategic networking, it converts bold concepts into real-world momentum to address critical gaps and launch pioneering advancements. Upcoming editions are scheduled in the USA, Singapore, and Dubai. Visit www.health2conf.com to learn more about this healthcare summit.
Contact Info:
Name: Bhawna Banga
Email: Send Email
Organization: Health 2.0 Conference
Website: https://www.health2conf.com/
Release ID: 89181204
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.